Improved Suspension Formulation Of A Corticosteroid For Administration By Inhalation

Patent No. EP2704724 (titled "Improved Suspension Formulation Of A Corticosteroid For Administration By Inhalation") was filed by Chiesi Farmaceutici on Apr 18, 2012. The application was issued on Oct 26, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JUMPJul 25, 2017ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2704724

CHIESI FARMACEUTICI
Application Number
EP12719304A
Filing Date
Apr 18, 2012
Status
Revoked
Feb 7, 2020
Publication Date
Oct 26, 2016